← back to search

Justin Lack

National Institutes of Health · US
Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic diversity and population structure, Cancer Immunotherapy and Biomarkers, and Vector-borne infectious diseases.
h-index
38
citations
7,081
works
247
NIH funding
primary concept
Biology
email

Recent publications

Genome assembly and annotation of Babesia rossi, a protozoan parasite for canine babesiosis
BMC Genomics 2025cited by 1position: middledoi
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations
Blood 2024cited by 33position: middledoi
Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
The Journal of Heart and Lung Transplantation 2024cited by 0position: middledoi
Human germline heterozygous gain-of-function <i>STAT6</i> variants cause severe allergic disease
The Journal of Experimental Medicine 2023cited by 107position: middledoi
Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis
Science Immunology 2023cited by 34position: middledoi
Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations
Journal of Allergy and Clinical Immunology 2022cited by 62position: middledoi
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
Blood Advances 2022cited by 56position: middledoi
Immunogenetics associated with severe coccidioidomycosis
JCI Insight 2022cited by 51position: middledoi
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nature Medicine 2021cited by 315position: middledoi
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
Nature Biotechnology 2021cited by 206position: middledoi
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
Nature Biotechnology 2021cited by 147position: middledoi
Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy
European Urology Focus 2018cited by 33position: middledoi
Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer
European Urology Focus 2017cited by 41position: middledoi
Circulating tumor cells capture disease evolution in advanced prostate cancer
Journal of Translational Medicine 2017cited by 28position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

David James VanderWeele · Northwestern University3 papers (2017–2018)Marc Gillard · University of Chicago3 papers (2017–2018)Gladell P. Paner · University of Chicago3 papers (2017–2018)Neelam Redekar · Virginia Tech2 papers (2024–2025)Donald J. Vander Griend · Illinois College2 papers (2017–2018)Andrea Pontier · University of Chicago2 papers (2017–2018)Maggie Cam · Center for Cancer Research2 papers (2017–2018)Woojin Park · National Heart Lung and Blood Institute1 papers (2024–2024)Soumya Korrapati · National Cancer Institute1 papers (2021–2021)Divya Gandla · New York University1 papers (2017–2017)Sanja Stevanović · Institute for Technology of Nuclear and other Mineral Raw Materials1 papers (2021–2021) · 1 papers (2025–2025)Colleen Schweitzer · Kite (United States)1 papers (2021–2021)Pamela A. Frischmeyer‐Guerrerio · National Institute of Dental and Craniofacial Research1 papers (2023–2023) · 1 papers (2018–2018)William C. Faquin · Massachusetts Eye and Ear Infirmary1 papers (2021–2021)Jessica L. Kinard · National Institute of Allergy and Infectious Diseases1 papers (2023–2023)Thomas J. Meyer · Frederick National Laboratory for Cancer Research1 papers (2021–2021)Kotoe Katayama · Tokyo Medical University1 papers (2018–2018)Adrian Bot · Centre Hospitalier Universitaire de Rennes1 papers (2021–2021)